DH332

antineoplastic

Networked: 1 relevant articles (0 outcomes, 1 trials/studies)

1.	Neoplasms (Cancer) 01/01/2014 - "In vivo studies of tumor-bearing BALB/c mice showed that DH332 significantly inhibited growth of J558 xenograft tumors. " 01/01/2014 - "The purpose of this study was to investigate anti-tumor effects and safety of DH332, a new β-carboline alkaloids derivatives in vitro and in vivo. "
2.	B-Cell Lymphoma (Lymphoma, B Cell) 01/01/2014 - "DH332, a synthetic β-carboline alkaloid, inhibits B cell lymphoma growth by activation of the caspase family."
3.	Lymphoma (Lymphomas) 01/01/2014 - "DH332 exerts effective antitumor activity in vitro and in vivo, and has the potential to be a promising drug candidate for lymphoma therapy." 01/01/2014 - "The effects of DH332 on human (RAMOS RA.1) and mouse (J558) B lymphoma cell lines were detected using a CCK-8 kit (Cell Counting Kit-8), and apoptosis was detected by flow cytometry with PI/annexinV staining. "

1.	Therapeutics